These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 15138570)
1. Analysis of telomerase activity and telomere length in bone and soft tissue tumors. Terasaki T; Kyo S; Takakura M; Maida Y; Tsuchiya H; Tomita K; Inoue M Oncol Rep; 2004 Jun; 11(6):1307-11. PubMed ID: 15138570 [TBL] [Abstract][Full Text] [Related]
2. Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas. Ulaner GA; Hoffman AR; Otero J; Huang HY; Zhao Z; Mazumdar M; Gorlick R; Meyers P; Healey JH; Ladanyi M Genes Chromosomes Cancer; 2004 Oct; 41(2):155-62. PubMed ID: 15287028 [TBL] [Abstract][Full Text] [Related]
3. Telomerase activity and human telomerase reverse transcriptase mRNA expression are correlated with clinical aggressiveness in soft tissue tumors. Tomoda R; Seto M; Tsumuki H; Iida K; Yamazaki T; Sonoda J; Matsumine A; Uchida A Cancer; 2002 Sep; 95(5):1127-33. PubMed ID: 12209700 [TBL] [Abstract][Full Text] [Related]
4. Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma. Engelhardt M; Albanell J; Drullinsky P; Han W; Guillem J; Scher HI; Reuter V; Moore MA Clin Cancer Res; 1997 Oct; 3(10):1849-57. PubMed ID: 9815573 [TBL] [Abstract][Full Text] [Related]
5. Telomerase activity in giant cell tumors of bone. Matsuo T; Hiyama E; Sugita T; Shimose S; Kubo T; Mochizuki Y; Adachi N; Kojima K; Sharman P; Ochi M Ann Surg Oncol; 2007 Oct; 14(10):2896-902. PubMed ID: 17653593 [TBL] [Abstract][Full Text] [Related]
6. Expression of human telomerase reverse transcriptase splice variants is well correlated with low telomerase activity in osteosarcoma cell lines. Fujiwara-Akita H; Maesawa C; Honda T; Kobayashi S; Masuda T Int J Oncol; 2005 Apr; 26(4):1009-16. PubMed ID: 15753996 [TBL] [Abstract][Full Text] [Related]
7. Telomerase activity and telomere length in primary and metastatic tumors from pediatric bone cancer patients. Sotillo-Piñeiro E; Sierrasesúmaga L; Patiñno-García A Pediatr Res; 2004 Feb; 55(2):231-5. PubMed ID: 14630995 [TBL] [Abstract][Full Text] [Related]
8. Telomerase activity in cell lines of pediatric soft tissue sarcomas. Kleideiter E; Schwab M; Friedrich U; Koscielniak E; Schafer BW; Klotz U Pediatr Res; 2003 Nov; 54(5):718-23. PubMed ID: 12904596 [TBL] [Abstract][Full Text] [Related]
9. Telomeres and telomerase in sarcomas. Matsuo T; Shimose S; Kubo T; Fujimori J; Yasunaga Y; Ochi M Anticancer Res; 2009 Oct; 29(10):3833-6. PubMed ID: 19846916 [TBL] [Abstract][Full Text] [Related]
10. Telomerase activity in soft-tissue and bone sarcomas. Aogi K; Woodman A; Urquidi V; Mangham DC; Tarin D; Goodison S Clin Cancer Res; 2000 Dec; 6(12):4776-81. PubMed ID: 11156234 [TBL] [Abstract][Full Text] [Related]
11. Telomerase activity and telomere length in lymphocytes from patients with cutaneous T-cell lymphoma. Wu K; Lund M; Bang K; Thestrup-Pedersen K Cancer; 1999 Sep; 86(6):1056-63. PubMed ID: 10491534 [TBL] [Abstract][Full Text] [Related]
12. Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status. Saini N; Srinivasan R; Chawla Y; Sharma S; Chakraborti A; Rajwanshi A Liver Int; 2009 Sep; 29(8):1162-70. PubMed ID: 19627485 [TBL] [Abstract][Full Text] [Related]
13. Lack of telomerase activity in lung carcinoids is dependent on human telomerase reverse transcriptase transcription and alternative splicing and is associated with long telomeres. Zaffaroni N; Villa R; Pastorino U; Cirincione R; Incarbone M; Alloisio M; Curto M; Pilotti S; Daidone MG Clin Cancer Res; 2005 Apr; 11(8):2832-9. PubMed ID: 15837730 [TBL] [Abstract][Full Text] [Related]
14. Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance. Alonso MM; Fueyo J; Shay JW; Aldape KD; Jiang H; Lee OH; Johnson DG; Xu J; Kondo Y; Kanzawa T; Kyo S; Bekele BN; Zhou X; Nigro J; McDonald JM; Yung WK; Gomez-Manzano C J Natl Cancer Inst; 2005 Nov; 97(21):1589-600. PubMed ID: 16264179 [TBL] [Abstract][Full Text] [Related]
15. Correlations of telomere length, telomerase activity, and telomeric-repeat binding factor 1 expression in colorectal carcinoma. Garcia-Aranda C; de Juan C; Diaz-Lopez A; Sanchez-Pernaute A; Torres AJ; Diaz-Rubio E; Balibrea JL; Benito M; Iniesta P Cancer; 2006 Feb; 106(3):541-51. PubMed ID: 16388518 [TBL] [Abstract][Full Text] [Related]
16. Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma. Gertler R; Rosenberg R; Stricker D; Friederichs J; Hoos A; Werner M; Ulm K; Holzmann B; Nekarda H; Siewert JR J Clin Oncol; 2004 May; 22(10):1807-14. PubMed ID: 15143073 [TBL] [Abstract][Full Text] [Related]